Gene overview
| Strategies/Algorithm: | closest_active | Ensembl ID: | ENSG00000162600 |
| Gene: | OMA1 | Gene type: | protein_coding |
| Strand: | - | External links: |
|
| Genomic region: | chr1:58415384-58546802 | Genome Browser: |   |
Super-enhancer search result of gene-based
| SE ID | SE Region | Sample ID | Tissue type | Biosample name | SE rank | Element | Common SNP | eQTL | Risk SNP | TFBS | CRISPR Cas9 | Gene |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SE_02_147700782 | chr1:57702922-57725066 |
Sample_02_1477 | Bone | EW-22 | 782 | 12 | 616 | 37 | 0 | 80 | 0 | DAB1,DAB1-AS1,OMA1 |
| SE_02_005700610 | chr1:57830262-57861189 |
Sample_02_0057 | Mammary gland | vHMEC | 610 | 5 | 797 | 4 | 6 | 175 | 107 | DAB1,OMA1 |
| SE_02_006500851 | chr1:58001733-58009078 |
Sample_02_0065 | Embryo | KO2-Late_G1 | 851 | 1 | 206 | 1 | 0 | 19 | 0 | DAB1,OMA1 |
| SE_02_006700599 | chr1:58002024-58008844 |
Sample_02_0067 | Embryo | AzH-G2/M | 599 | 1 | 196 | 1 | 0 | 18 | 0 | DAB1,OMA1 |
| SE_02_006600246 | chr1:58002268-58009111 |
Sample_02_0066 | Embryo | AzL-S_phase | 246 | 1 | 192 | 1 | 0 | 19 | 0 | DAB1,OMA1 |
| SE_02_006400891 | chr1:58002314-58008001 |
Sample_02_0064 | Embryo | DN-Early_G1 | 891 | 2 | 165 | 1 | 0 | 17 | 0 | DAB1,OMA1 |
| SE_01_004400408 | chr1:58134259-58161706 |
Sample_01_0044 | Haematopoietic and lymphoid tissue | Loucy | 408 | 4 | 719 | 0 | 2 | 111 | 43 | DAB1,OMA1 |
| SE_01_004000260 | chr1:58135273-58165611 |
Sample_01_0040 | Haematopoietic and lymphoid tissue | Karpas-422 | 260 | 4 | 796 | 1 | 3 | 122 | 43 | DAB1,OMA1 |
| SE_02_011700285 | chr1:58135743-58163430 |
Sample_02_0117 | Haematopoietic and lymphoid tissue | KARPAS-422 | 285 | 4 | 731 | 0 | 2 | 114 | 43 | DAB1,OMA1 |
| SE_02_106500504 | chr1:58143434-58161616 |
Sample_02_1065 | Lymphoma | KARPAS-422_DMSO_8d | 504 | 3 | 463 | 0 | 1 | 87 | 43 | DAB1,OMA1 |
| SE_01_004400690 | chr1:58388937-58396396 |
Sample_01_0044 | Haematopoietic and lymphoid tissue | Loucy | 690 | 1 | 202 | 1 | 2 | 29 | 0 | DAB1,OMA1 |
| SE_02_139900462 | chr1:58392291-58412018 |
Sample_02_1399 | Bone | U2OS_siMLL3.1 | 462 | 13 | 548 | 7 | 2 | 40 | 0 | OMA1 |
| SE_02_139800334 | chr1:58392505-58413672 |
Sample_02_1398 | Bone | U2OS_siNC | 334 | 12 | 595 | 9 | 2 | 43 | 0 | OMA1 |
| SE_02_028100398 | chr1:58393977-58414323 |
Sample_02_0281 | Bone | U2OS | 398 | 2 | 569 | 10 | 2 | 33 | 0 | OMA1 |
| SE_02_088601927 | chr1:58394587-58413457 |
Sample_02_0886 | Skin | foreskin_ p63KLF4 | 1927 | 4 | 533 | 9 | 2 | 29 | 0 | OMA1 |
| SE_02_086900989 | chr1:58394851-58413232 |
Sample_02_0869 | Fibroblast | VH10_NO_UV | 989 | 11 | 518 | 8 | 2 | 27 | 0 | OMA1 |
| SE_02_113400571 | chr1:58395609-58413009 |
Sample_02_1134 | Bone | U2OS-interphase | 571 | 8 | 500 | 8 | 2 | 27 | 0 | OMA1 |
| SE_02_086400202 | chr1:58515522-58546777 |
Sample_02_0864 | Malignant rhaboid tumor | TTC1240_SMARCB1_K364del | 202 | 3 | 899 | 195 | 2 | 68 | 308 | OMA1,TACSTD2 |
| SE_02_086300245 | chr1:58515588-58546727 |
Sample_02_0863 | Malignant rhaboid tumor | TTC1240_empty | 245 | 4 | 891 | 192 | 2 | 68 | 303 | OMA1,TACSTD2 |
| SE_02_086500200 | chr1:58515639-58546744 |
Sample_02_0865 | Malignant rhaboid tumor | TTC1240_SMARCB1_R377H | 200 | 6 | 892 | 193 | 2 | 67 | 303 | OMA1,TACSTD2 |
| SE_02_139200472 | chr1:58516006-58546822 |
Sample_02_1392 | Peripheral blood | Mac-2A_ALK- | 472 | 6 | 890 | 195 | 2 | 65 | 323 | OMA1,TACSTD2 |
| SE_02_138800104 | chr1:58516037-58546773 |
Sample_02_1388 | Peripheral blood | JB6_ALK+ | 104 | 6 | 887 | 195 | 2 | 65 | 308 | OMA1,TACSTD2 |
| SE_02_086200221 | chr1:58516072-58546740 |
Sample_02_0862 | Malignant rhaboid tumor | TTC1240_SMARCB1 FL | 221 | 2 | 881 | 193 | 2 | 65 | 303 | OMA1,TACSTD2 |
| SE_02_138600441 | chr1:58516129-58531412 |
Sample_02_1386 | Peripheral blood | Karpas-299_ALK+ | 441 | 9 | 434 | 81 | 1 | 23 | 64 | OMA1,TACSTD2 |
| SE_02_086600247 | chr1:58516137-58546739 |
Sample_02_0866 | Malignant rhaboid tumor | TTC1240_SMARCB1_delCC | 247 | 5 | 881 | 193 | 2 | 65 | 303 | OMA1,TACSTD2 |
| SE_02_074400766 | chr1:58539684-58549726 |
Sample_02_0744 | Embryo | ES derived cardiac mesoderm_day5 | 766 | 3 | 315 | 74 | 0 | 17 | 122 | OMA1,TACSTD2 |
| SE_02_049500212 | chr1:58544362-58551815 |
Sample_02_0495 | Islets | differentiated hESCs Early LSD1 inhibition PP2 | 212 | 2 | 234 | 52 | 0 | 14 | 122 | OMA1,TACSTD2 |
| SE_02_052500566 | chr1:58544497-58551161 |
Sample_02_0525 | Pancreas | iPS derived pancreatic precursor cells_Lane1 | 566 | 2 | 206 | 46 | 0 | 14 | 122 | OMA1,TACSTD2 |
| SE_02_049400501 | chr1:58544569-58551488 |
Sample_02_0494 | Islets | differentiated hESCs Late pancreatic progenitor cells | 501 | 2 | 215 | 48 | 0 | 14 | 122 | OMA1,TACSTD2 |
| SE_02_093200195 | chr1:58544774-58574359 |
Sample_02_0932 | Embryo | H9 WT_1 | 195 | 6 | 892 | 212 | 1 | 14 | 122 | OMA1,TACSTD2 |
| SE_02_075300879 | chr1:58547757-58551997 |
Sample_02_0753 | Embryo | ES-derived progenitors_FG type | 879 | 1 | 132 | 30 | 0 | 0 | 0 | TACSTD2,OMA1 |
| SE_02_093100414 | chr1:58548897-58574332 |
Sample_02_0931 | Embryo | H9 UTXKO | 414 | 5 | 768 | 186 | 1 | 0 | 0 | TACSTD2,OMA1 |
| SE_02_093400567 | chr1:58549778-58566285 |
Sample_02_0934 | Embryo | H7-WT | 567 | 5 | 514 | 131 | 0 | 0 | 0 | TACSTD2,OMA1 |
| SE_02_093300239 | chr1:58550162-58567139 |
Sample_02_0933 | Embryo | H7 UTXKO | 239 | 3 | 538 | 137 | 0 | 0 | 0 | TACSTD2,OMA1 |
| SE_02_126900925 | chr1:58572862-58593859 |
Sample_02_1269 | Bone | Im-GCT-4072_G34W-repair_WT_A4 | 925 | 4 | 586 | 121 | 3 | 0 | 432 | TACSTD2,OMA1 |
Genomic distribution of SEs associated with OMA1